Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the efficacy and safety of PDC-339 for acute erosive gastritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Gastritis

Drugs mentioned

• PDC-339

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Erosive Gastritis | Phase 2 | Status: COMPLETED